These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9869558)

  • 1. Eradication by ceftriaxone of Streptococcus pneumoniae isolates with increased resistance to penicillin in cases of acute otitis media.
    Gehanno P; Nguyen L; Barry B; Derriennic M; Pichon F; Goehrs JM; Berche P
    Antimicrob Agents Chemother; 1999 Jan; 43(1):16-20. PubMed ID: 9869558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriologic and clinical efficacy of one day vs. three day intramuscular ceftriaxone for treatment of nonresponsive acute otitis media in children.
    Leibovitz E; Piglansky L; Raiz S; Press J; Leiberman A; Dagan R
    Pediatr Infect Dis J; 2000 Nov; 19(11):1040-5. PubMed ID: 11099083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-day twice daily cefdinir therapy for acute otitis media: microbiologic and clinical efficacy.
    Block SL; Hedrick JA; Kratzer J; Nemeth MA; Tack KJ
    Pediatr Infect Dis J; 2000 Dec; 19(12 Suppl):S153-8. PubMed ID: 11144397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin.
    Dagan R; Abramson O; Leibovitz E; Lang R; Goshen S; Greenberg D; Yagupsky P; Leiberman A; Fliss DM
    Pediatr Infect Dis J; 1996 Nov; 15(11):980-5. PubMed ID: 8933545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriologic efficacy of a three-day intramuscular ceftriaxone regimen in nonresponsive acute otitis media.
    Leibovitz E; Piglansky L; Raiz S; Greenberg D; Yagupsky P; Press J; Fliss DM; Leiberman A; Dagan R
    Pediatr Infect Dis J; 1998 Dec; 17(12):1126-31. PubMed ID: 9877360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of acute otitis media caused by resistant pneumococci in infants.
    Roger G; Carles P; Pangon B; Thien HV; Polonovski JM; Begue P; Garabedian EN
    Pediatr Infect Dis J; 1998 Jul; 17(7):631-8. PubMed ID: 9686731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogens isolated during treatment failures in otitis.
    Gehanno P; N'Guyen L; Derriennic M; Pichon F; Goehrs JM; Berche P
    Pediatr Infect Dis J; 1998 Oct; 17(10):885-90. PubMed ID: 9802629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora.
    Cohen R; Navel M; Grunberg J; Boucherat M; Geslin P; Derriennic M; Pichon F; Goehrs JM
    Pediatr Infect Dis J; 1999 May; 18(5):403-9. PubMed ID: 10353511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997.
    Wald ER; Mason EO; Bradley JS; Barson WJ; Kaplan SL;
    Pediatr Infect Dis J; 2001 Jan; 20(1):34-9. PubMed ID: 11176564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media.
    Dagan R; Hoberman A; Johnson C; Leibovitz EL; Arguedas A; Rose FV; Wynne BR; Jacobs MR
    Pediatr Infect Dis J; 2001 Sep; 20(9):829-37. PubMed ID: 11734759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of single-dose ceftriaxone in experimental otitis media induced by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.
    Barry B; Muffat-Joly M; Bauchet J; Faurisson F; Gehanno P; Pocidalo JJ; Carbon C
    Antimicrob Agents Chemother; 1996 Sep; 40(9):1977-82. PubMed ID: 8878566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrent infection.
    Arguedas A; Dagan R; Leibovitz E; Hoberman A; Pichichero M; Paris M
    Pediatr Infect Dis J; 2006 Mar; 25(3):211-8. PubMed ID: 16511382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media.
    Gehanno P; Lenoir G; Berche P
    Antimicrob Agents Chemother; 1995 Jan; 39(1):271-2. PubMed ID: 7695322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single intramuscular dose of ceftriaxone changes nasopharyngeal bacterial flora in children with acute otitis media.
    Heikkinen T; Saeed KA; McCormick DP; Baldwin C; Reisner BS; Chonmaitree T
    Acta Paediatr; 2000 Nov; 89(11):1316-21. PubMed ID: 11106042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of pneumococcal nasopharyngeal carriage in children with nonresponsive acute otitis media treated with two regimens of intramuscular ceftriaxone.
    Haiman T; Leibovitz E; Piglansky L; Press J; Yagupsky P; Leiberman A; Dagan R
    Pediatr Infect Dis J; 2002 Jul; 21(7):642-7. PubMed ID: 12237596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiology of acute otitis media in Costa Rican children.
    Arguedas A; Loaiza C; Perez A; Vargas F; Herrera M; Rodriguez G; Gutierrez A; Mohs E
    Pediatr Infect Dis J; 1998 Aug; 17(8):680-9. PubMed ID: 9726340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media.
    McLinn S; Williams D
    Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S3-9. PubMed ID: 8878239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management.
    Block SL; Harrison CJ; Hedrick JA; Tyler RD; Smith RA; Keegan E; Chartrand SA
    Pediatr Infect Dis J; 1995 Sep; 14(9):751-9. PubMed ID: 8559623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large dosage amoxicillin/clavulanate, compared with azithromycin, for the treatment of bacterial acute otitis media in children.
    Hoberman A; Dagan R; Leibovitz E; Rosenblut A; Johnson CE; Huff A; Bandekar R; Wynne B
    Pediatr Infect Dis J; 2005 Jun; 24(6):525-32. PubMed ID: 15933563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriologic and clinical efficacy of oral gatifloxacin for the treatment of recurrent/nonresponsive acute otitis media: an open label, noncomparative, double tympanocentesis study.
    Leibovitz E; Piglansky L; Raiz S; Greenberg D; Hamed KA; Ledeine JM; Press J; Leiberman A; Echols RM; Pierce PF; Jacobs MR; Dagan R
    Pediatr Infect Dis J; 2003 Nov; 22(11):943-9. PubMed ID: 14614364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.